Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Laboratory Model for Relapse to Sedentary Behavior

17 de marzo de 2022 actualizado por: Kathryn Kestner, West Virginia University

Laboratory Model for Relapse to Sedentary Behavior: Toward a Physically Active West Virginia

Physical inactivity is a key risk factor for noncommunicable illnesses such as cancer and cardiovascular disease-the two leading causes of death in West Virginia. The World Health Organization recommends muscle-strengthening activities 2 or more days per week and a minimum of either 150 minutes of moderate-intensity activity or 75 minutes of vigorous-intensity activity per week. Yet, only one in five adults in the United States meets these recommendations. Even more alarming is that 33.2% of West Virginians report that they did not engage in any physical activity in the past month. Incentive-based interventions increase physical activity in the short term, but incentives for healthy behavior are generally discontinued after some period of time, and relapse of unhealthy behavior is common. Thus, there is a critical need to develop interventions that result in both immediate and lasting engagement in activity. The overall objective and specific aim of the proposed project is to evaluate a brief laboratory model of relapse into sedentary behavior following incentive-based interventions that is based on Behavioral Momentum Theory. The central hypothesis is that incentives will increase activity, but relapse will occur in the brief model, like what occurs in extended clinical treatment. Development of a laboratory model of relapse into sedentary behavior (the expected outcome of the proposed project) will inform future translational research, eventually leading to clinical applications of large-scale physical-activity interventions that result in significant and immediate behavior change and that minimize relapse.

Descripción general del estudio

Estado

Terminado

Condiciones

Intervención / Tratamiento

Descripción detallada

Physical inactivity is a key risk factor for noncommunicable illnesses such as cancer and cardiovascular disease (CVD)-the two leading causes of death in West Virginia. Physical inactivity is fundamentally a behavior problem, and there is a growing body of research supporting the use of incentive-based interventions to increase physical activity. In such interventions, participants earn incentives such as money, tokens or points, entries into prize drawings, or fitness-related commodities (e.g., gym memberships) by meeting defined goals (e.g., daily steps, energy expenditure, fitness classes).

A crucial feature of any successful intervention is sustained behavior-change following the removal or decrease in supports. However, most evaluations of incentive-based interventions are completed on a short-term scale (4 to 12 weeks) and often fail to provide data on follow-up. The studies that follow participants after the discontinuation of incentives often show relapse to sedentary behavior following intervention. Similar relapse is common following incentive-based interventions for other health-related behavior. Laboratory models of relapse prevention have informed treatment for these other forms of health-related behavior, but they have yet to be extended to interventions addressing sedentary behavior.

The investigators' long-term goal is to develop practical interventions that sustain increases in physical activity and thereby decrease a significant risk factor for disease (e.g., cancer, diabetes). The overall objective of the proposed project is to evaluate a brief laboratory model of relapse that is based on basic behavioral research grounded in Behavioral Momentum Theory. The central hypothesis is that incentives in the brief model will produce the expected increases in physical activity relative to no-incentive controls, but that these gains will be rapidly lost when the incentives are discontinued. This hypothesis is based other laboratory-based models of relapse (e.g., illicit drug use and challenging behavior), which mirrored outcomes of, and led to advances in clinical, treatment. The rationale for this project is that a laboratory model of relapse of sedentary behavior will inform future translational research and lead to large-scale clinical trials of incentives to improve physical activity that result in large, immediate behavioral change and that minimize subsequent relapse.

The central hypothesis is that incentives in the brief model will produce the expected increases in physical activity relative to no-incentive controls, but that these gains will be rapidly lost when the incentives are discontinued. These outcomes would suggest that the brief model produces outcomes similar to those obtained in more extended clinical treatment.

Approach The anticipated number of participants is 30 individuals (age 18-74). Participants will attend a single 90-min laboratory appointment. The laboratory space will be equipped with a treadmill, comfortable seating, and leisure activities. A licensed nurse will screen participants to ensure they are healthy enough to engage in physical activity and will remain present for the duration of participation to provide medical assistance in the unlikely event that it is needed. Block randomization will be used to assign participants to one of three groups (one experimental and two control groups). All groups will experience three phases of the study. Opportunities for sedentary leisure and physical activities will be continuously available throughout all phases. The first phase will mimic pre-intervention conditions; there will be a variety of activities available. No incentives for engaging in physical activity will be provided, although such activities will be available. For the Relapse (experimental) Group, the second phase will mimic an incentive-based intervention in which participants can earn monetary incentives for engaging in physical activity. Then, during the third phase, the incentives will be discontinued the Fatigue Control group will experience the same conditions for Phase 1 and 2, but they will continue to earn incentives during Phase 3. The No-Incentive Control group will not earn incentives during any phase to control for the possibility that participants will engage in some physical activity in the absence of incentives.

Participants will wear a heart rate monitor throughout the study to provide real-time data on activity level and trained research assistants will use software to score time-stamped duration of engagement in available activities (e.g., walking, sitting). A one-way ANOVA will be used to compare mean durations of physical activity across groups. A power analysis[23] shows that including 30 participants (10 in each group) will provide sufficient power to detect an effect size of 0.8 at an alpha of 0.05. Additionally, the investigators will use the heart rate data for preliminary analyses of mediation and moderation effects.

Tipo de estudio

Intervencionista

Inscripción (Actual)

31

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Ubicaciones de estudio

    • West Virginia
      • Morgantown, West Virginia, Estados Unidos, 26506
        • West Virginia University

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

18 años a 74 años (Adulto, Adulto Mayor)

Acepta Voluntarios Saludables

Géneros elegibles para el estudio

Todos

Descripción

Inclusion Criteria:

  • Adults of any gender between the ages of 18 and 74 years will be eligible to participate in a pre-screening session to determine whether they meet inclusion criteria. During the pre-screening session, eligibility will be assessed with the Physical Activity Readiness Questionnaire for Everyone (2011) and the individual's blood pressure reading. Participants are eligible if they meet these criteria, complete the screening tools listed above, and do not meet any of the exclusion criteria listed below.

Exclusion Criteria:

  • During the pre-screening session, eligibility will be assessed with the Physical Activity Readiness Questionnaire for Everyone (2011) and the individual's blood pressure reading. Individuals will not be eligible to participate if any of the following occur:

    1. The participant responds that they are or may be pregnant.
    2. The participant responds "Yes" to any question on the Physical Activity Readiness Questionnaire for Everyone with the exception of reporting a mental health condition (e.g., anxiety, depression, attention-deficit hyperactivity disorder) that is well controlled by medication and/or other therapies.
    3. The participant's blood pressure is 160 mm Hg or higher systolic or 90 mm Hg or higher diastolic.

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Otro
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación paralela
  • Enmascaramiento: Único

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: Relapse (experimental) Group
Opportunities for sedentary leisure and physical activities will be continuously available throughout all phases. Each phase will last 20 minutes. The first phase will mimic pre-intervention conditions; there will be a variety of activities available. No incentives for engaging in physical activity will be provided, although such activities will be available. For the Relapse (experimental) Group, the second phase will mimic an incentive-based intervention in which participants can earn monetary incentives for engaging in physical activity. Then, during the third phase, the incentives will be discontinued.
Participants will earn $1 per minute of engagement in physical activity.
Experimental: Fatigue Control Group
Opportunities for sedentary leisure and physical activities will be continuously available throughout all phases. Each phase will last 20 minutes. The first phase will mimic pre-intervention conditions; there will be a variety of activities available. No incentives for engaging in physical activity will be provided, although such activities will be available. The second phase will mimic an incentive-based intervention in which participants can earn monetary incentives for engaging in physical activity. Participants in this arm will continue to earn incentives during Phase 3 to control reductions in physical activity due to fatigue.
Participants will earn $1 per minute of engagement in physical activity.
Sin intervención: No-Incentive Control Group
Opportunities for sedentary leisure and physical activities will be continuously available throughout all phases. Each phase will last 20 minutes. Participants in this arm will not earn incentives during any of the three phases to control for the possibility that participants will engage in some physical activity in the absence of incentives.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Minutes spent engaging in physical activity during each phase
Periodo de tiempo: Participants are in the lab for one 1-hour session. These observational data will be recorded continuously (every second) during the 1-Hour session.
Trained research assistants will use software to score time-stamped duration of engagement in physical activity (defined as walking or running on the treadmill).
Participants are in the lab for one 1-hour session. These observational data will be recorded continuously (every second) during the 1-Hour session.
Minutes spent engaging in sedentary activity during each phase
Periodo de tiempo: Participants are in the lab for one 1-hour session. These observational data will be recorded continuously (every second) during the 1-Hour session.
Trained research assistants will use software to score time-stamped duration of engagement in sedentary activity (defined as sitting or standing).
Participants are in the lab for one 1-hour session. These observational data will be recorded continuously (every second) during the 1-Hour session.
Average heart rate for each phase
Periodo de tiempo: Participants are in the lab for one 1-hour session. The polar heart rate monitor will be worn at all times during the session and the device samples heart rate at least one time per second during the 1-Hour session.
The heart rate monitor will sample and record heart rate on a second-by-second basis. The average heart rate will be calculated for each phase.
Participants are in the lab for one 1-hour session. The polar heart rate monitor will be worn at all times during the session and the device samples heart rate at least one time per second during the 1-Hour session.
Real-time record of heart rate
Periodo de tiempo: Participants are in the lab for one 1-hour session. The polar heart rate monitor will be worn at all times during the session and the device samples heart rate at least one time per second during the 1-Hour session.
The heart rate monitor will sample and record heart rate on a second-by-second basis and produce a time-stamped record that can be graphed and analyzed as time-series data.
Participants are in the lab for one 1-hour session. The polar heart rate monitor will be worn at all times during the session and the device samples heart rate at least one time per second during the 1-Hour session.

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Real-time record of activity zone
Periodo de tiempo: Participants are in the lab for one 1-hour session. The polar heart rate monitor will be worn at all times during the session and the device samples heart rate at least one time per second during the 1-Hour session.
The heart rate monitor will produce a record of activity level based on heart rate data and will produce a time-stamped record that can be graphed and analyzed as time-series data. The software calculates activity zone based on percentage of maximum heart rate. There are 5 zones of activity.
Participants are in the lab for one 1-hour session. The polar heart rate monitor will be worn at all times during the session and the device samples heart rate at least one time per second during the 1-Hour session.
Average number of minutes in each activity zone during each phase
Periodo de tiempo: Participants are in the lab for one 1-hour session. The polar heart rate monitor will be worn at all times during the session and the device samples heart rate at least one time per second during the 1-Hour session.
The heart rate monitor will produce a record of activity level based on heart rate data and will produce a time-stamped record. The software calculates the activity zone based on the percentage of maximum heart rate. Average number of minutes spend in each zone will be calculated for each phase.
Participants are in the lab for one 1-hour session. The polar heart rate monitor will be worn at all times during the session and the device samples heart rate at least one time per second during the 1-Hour session.
Systolic and Diastolic Blood Pressure reading
Periodo de tiempo: Screening session and during the 1-hour session.
Systolic or Diastolic Blood Pressure will be measured using a blood pressure monitor.
Screening session and during the 1-hour session.
Duration of time spend engaging in each activity type.
Periodo de tiempo: Participants are in the lab for one 1-hour session. These observational data will be recorded continuously (every second) during the 1-Hour session.
Trained research assistants will use software to score time-stamped duration of engagement. There will be 10 activity codes (Treadmill; Moving, Treadmill; Not Moving, Sitting, Standing, Watching screen (phone, computer, etc), Looking at paper or book, Sleeping or eyes closed, Other Leisure, Other gross-motor movement, and interacting with experimenter).
Participants are in the lab for one 1-hour session. These observational data will be recorded continuously (every second) during the 1-Hour session.

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Investigadores

  • Investigador principal: Kathryn M Kestner, PhD, West Virginia University

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

9 de diciembre de 2019

Finalización primaria (Actual)

15 de marzo de 2022

Finalización del estudio (Actual)

15 de marzo de 2022

Fechas de registro del estudio

Enviado por primera vez

4 de noviembre de 2019

Primero enviado que cumplió con los criterios de control de calidad

8 de noviembre de 2019

Publicado por primera vez (Actual)

13 de noviembre de 2019

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

21 de marzo de 2022

Última actualización enviada que cumplió con los criterios de control de calidad

17 de marzo de 2022

Última verificación

1 de marzo de 2022

Más información

Términos relacionados con este estudio

Términos MeSH relevantes adicionales

Otros números de identificación del estudio

  • 1810337844

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

Descripción del plan IPD

Observational & behavioral data collected during the proposed project will be made available (the tentative plan is to do so through The Research Repository @ WVU). Submitted data will conform with relevant data and terminology standards. All identifiable information will be removed to protect confidentiality.

Marco de tiempo para compartir IPD

Immediately following publication for at least 5 years.

Criterios de acceso compartido de IPD

Anyone interested in accessing the data.

Tipo de información de apoyo para compartir IPD

  • PROTOCOLO DE ESTUDIO
  • CIF

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Ensayos clínicos sobre Performance-based incentives

3
Suscribir